We are live on
!
Find out more
CFM
Capricorn Fund Managers Portfolio holdings
AUM
$1.27B
1-Year Est. Return
70.17%
This Fund
S&P 500
This Quarter
Est. Return
+15.21%
1 Year Est. Return
+70.17%
3 Year Est. Return
+169.21%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
+$627M
(+98%)
Cap. Flow
+$530M
Cap. Flow
% of AUM
41.74%
Top 10 Holdings %
Top 10 Hldgs %
26.97%
Holding
219
New
105
Increased
29
Reduced
25
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPL Financial
LPLA
|
+$58.5M |
| 2 |
BP
BP
|
+$43.2M |
| 3 |
Shell
SHEL
|
+$39.6M |
| 4 |
Applovin
APP
|
+$29.6M |
| 5 |
ING
ING
|
+$26.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adaptive Biotechnologies
ADPT
|
+$19.4M |
| 2 |
Norfolk Southern
NSC
|
+$17.5M |
| 3 |
Primerica
PRI
|
+$17M |
| 4 |
EA
Electronic Arts
EA
|
+$15.5M |
| 5 |
Phibro Animal Health
PAHC
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.12% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.53% |
| 4 | Technology | 12.07% |
| 5 | Communication Services | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Burford Capital
BUR
$953M
| $554K | 0.04% |
135,000
| – | – |
|
152
Pfizer
PFE
$162B
| $533K | 0.04% |
22,130
-143,600
| -87% | -$3.76M |
|
|
LCLN
153
Lincoln International
LCLN
$948M
| $528K | 0.04% |
+22,139
| New | +$522K |
|
154
Sherwin-Williams
SHW
$81B
| $526K | 0.04% |
+1,528
| New | +$488K |
|
155
Merck
MRK
$371B
| $514K | 0.04% |
+4,000
| New | +$468K |
|
|
156
Adaptive Biotechnologies
ADPT
$3.88B
| $487K | 0.04% |
22,693
-1,269,080
| -98% | -$19.4M |
|
|
ANGX
157
Angel Studios
ANGX
$857M
| $480K | 0.04% |
+130,806
| New | +$371K |
|
158
Credo Technology Group
CRDO
$32B
| $459K | 0.04% |
+1,686
| New | +$333K |
|
159
Johnson & Johnson
JNJ
$663B
| $432K | 0.03% |
+1,700
| New | +$396K |
|
|
TLX
160
Telix Pharmaceuticals
TLX
$4.06B
| $416K | 0.03% |
+36,100
| New | +$368K |
|
|
HMH
161
HMH Holding Inc
HMH
$235M
| $394K | 0.03% |
+21,000
| New | +$430K |
|
|
BORR
162
Borr Drilling
BORR
$1.4B
| $372K | 0.03% |
90,000
| – | – |
|
163
Restaurant Brands International
QSR
$28B
| $369K | 0.03% |
5,089
-60,000
| -92% | -$4.57M |
|
|
LIFE
164
Ethos Technologies Inc
LIFE
$2.54B
| $367K | 0.03% |
20,234
-3,466
| -15% | -$62.6K |
|
165
Tidewater
TDW
$4.69B
| $366K | 0.03% |
5,500
| – | – |
|
166
MasTec
MTZ
$19.1B
| $366K | 0.03% |
+880
| New | +$336K |
|
167
EQT Corp
EQT
$34.5B
| $346K | 0.03% |
+6,500
| New | +$365K |
|
168
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.68B
| $325K | 0.03% |
+80,000
| New | +$4.1M |
|
169
Vaalco Energy
EGY
$629M
| $305K | 0.02% |
60,000
| – | – |
|
170
Rocket Companies
RKT
$39.8B
| $293K | 0.02% |
18,594
-1,474
| -7% | -$21.2K |
|
171
Ovintiv
OVV
$17.9B
| $284K | 0.02% |
+5,400
| New | +$308K |
|
|
UROY
172
Uranium Royalty Corp
UROY
$1.7B
| $278K | 0.02% |
+100,000
| New | +$351K |
|
173
Nextpower Inc. Common Stock
NXT
$12.8B
| $268K | 0.02% |
+2,250
| New | +$278K |
|
174
Noble Corp
NE
$7.29B
| $257K | 0.02% |
6,900
| – | – |
|
175
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $201K | 0.02% |
+1,000
| New | +$725K |
|
Similar funds
JLBC
KA
BFS
WA
JMFC
JTWM
MIA
CAM
Capricorn Fund Managers's Q2 2026 Portfolio in Review
As of Q2 2026, Capricorn Fund Managers held 219 positions worth $1.27B, up 98% from $641M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capricorn Fund Managers deployed $530M of net new capital in Q2 2026, opening 105 new positions and adding to 29 existing holdings. Its largest new stake was LPL Financial: 194,812 shares worth $54.9M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Adaptive Biotechnologies, an estimated $19.4M trimmed.
- Capricorn Fund Managers's largest Q2 2026 buy was LPL Financial: 194,812 shares worth $54.9M.
- Capricorn Fund Managers added most to KKR & Co in Q2 2026, an estimated $24.1M increase.
- Capricorn Fund Managers's biggest Q2 2026 reduction was Adaptive Biotechnologies, cutting an estimated $19.4M.
- Capricorn Fund Managers fully exited Norfolk Southern in Q2 2026, selling an estimated $17.5M.
- Capricorn Fund Managers's ten largest holdings make up 27% of its $1.27B portfolio in Q2 2026.
- Capricorn Fund Managers opened 105 new positions and closed 41 in Q2 2026.
- Capricorn Fund Managers's portfolio value rose 98% quarter-over-quarter to $1.27B.
Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.